MilliporeSigma reports that it has invested more than €300 million ($324.5 million) into a new bioprocessing production center in Daejeon, South Korea. The new bioproduction center will provide essential biotech products such as dry powder cell culture media, process liquids, pre-GMP small-scale manufacturing and sterile sampling systems. Covering an area of 43,000 m2, the facility will include advanced production capacities, a distribution center, and an automated warehouse. Source: Genetic Engineering News 22/3/2024